Review
Published on 14 Jul 2022
Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.961421
- 4,522 views
- 4 citations
16 articles related to "Plasma Cell Malignancy"
Articles
Original Research
Published on 01 Aug 2022
NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.967811
- 6,101 views
- 30 citations
Original Research
Published on 30 Nov 2021
A Five-Gene Risk Score Model for Predicting the Prognosis of Multiple Myeloma Patients Based on Gene Expression Profiles
in Computational Genomics
Frontiers in Genetics
doi 10.3389/fgene.2021.785330
- 6,652 views
- 6 citations
Review
Published on 09 Jun 2022
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.905484
- 12,765 views
- 8 citations
Review
Published on 11 Dec 2018
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2018.00566
- 13,800 views
- 56 citations
Review
Published on 24 Apr 2020
Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2020.00501
- 40,563 views
- 94 citations
Original Research
Published on 06 Apr 2022
SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.841308
- 5,359 views
- 5 citations
Systematic Review
Published on 13 May 2025
The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis
in Hematology
Frontiers in Medicine
doi 10.3389/fmed.2025.1575914
- 4,395 views
Brief Research Report
Published on 17 Jul 2023
BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1196005
- 7,139 views
- 5 citations
Original Research
Published on 28 Aug 2025
Identification and validation of a histone modification-related gene signature to predict the prognosis of multiple myeloma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1613631
- 2,407 views
Original Research
Published on 04 Aug 2023
Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1239614
- 6,942 views
- 16 citations
Original Research
Published on 11 May 2022
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.842200
- 9,392 views
- 11 citations
Hypothesis and Theory
Published on 23 Dec 2013
Apoptotic Machinery Diversity in Multiple Myeloma Molecular Subtypes
in B Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2013.00467
- 7,891 views
- 21 citations
Review
Published on 24 Apr 2019
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2019.00760
- 25,329 views
- 68 citations
Original Research
Published on 09 May 2025
Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1547138
- 4,258 views
Case Report
Published on 27 Dec 2016
The Importance of an In-depth Study of Immunoglobulin Gene Rearrangements When Ascertaining the Clonal Relationship between Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma
in B Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2016.00625
- 5,492 views
- 8 citations